Price to Earning ratio Analysis of Orion Biotech Opp Corp. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY PE
Period Ending - Dec-22
Not Good PE
23.37
Period Ending - Dec-21
Very Poor PE
-353.00
Growth
106.62 %
Trailing Twelve Months PE
Period Ending - Dec-22
Excellent PE
0.0000
PE Analysis of Orion Biotech Opp Corp.
| P/E Ratio 0.0000 of Orion Biotech Opp Corp. shows that stock price is low compared to company earnings and may be undervalued. |
| PE Ratio of ORIA rose handsomely by 106.62 % this year. |
Other PE Related Info of ORIA that may interest you.
Orion Biotech Opp Corp. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ORIA | 10.23 | 10.23 | 0 % | Shell Companies |
Defination of Price to Earning
PE Ratio measures the relationship between the company's current stock price and EPS (Earnings Per Share). PE Ratio indicates how many times investors pay money to get 1 rupee of return. It is one of the important parameters to evaluate whether a company's stock price is overvalued or undervalued. more ..
PE Related Ratios
| PriceToSalesRatio | PriceToBookRatio | PriceToCashFlowRatio |
Tsr Value Index
| Good Value | |
FY - Historical Price to Earning of Orion Biotech Opp Corp.
| Period | Dec-22 | Dec-21 |
|---|---|---|
| PE | 23.37 | -353.00 |
| Change | 106.62 % |
FY Chart of Price to Earning of Orion Biotech Opp Corp.
Note : All Data Generated at the End of Trading Hours (EOD Data)